From Name:
From Email:
To Name:
To Email:

Optional Message:


Pfizer to seek menopause drug approval

from The Wall Street Journal

Pfizer is preparing to seek U.S. regulatory approval to sell a new menopause drug that could pose an alternative to the company's older hormone-replacement therapies, which have been tied to safety risks. However, repeated delays in developing the new drug, Aprela, have raised questions about its potential. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063